➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Medtronic
McKinsey
Colorcon
Dow

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ETOMIDATE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Etomidate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00175747 ↗ A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) Completed National Cancer Institute (NCI) Phase 2/Phase 3 2000-01-01 Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia.
NCT00175747 ↗ A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) Completed University of British Columbia Phase 2/Phase 3 2000-01-01 Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia.
NCT00248729 ↗ Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital. Completed St. Luke's Hospital, Pennsylvania Phase 2 2002-10-01 The objective of this study was to compare the utility of etomidate and midazolam in helping patients to relax when there was a need for the placement of a ventilation tube by medics who were transporting patients to a hospital in an ambulance.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Etomidate

Condition Name

Condition Name for Etomidate
Intervention Trials
Anesthesia 4
Hemodynamic Instability 3
Depression 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Etomidate
Intervention Trials
Depression 4
Myoclonus 3
Coronary Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Etomidate

Trials by Country

Trials by Country for Etomidate
Location Trials
United States 20
China 12
Poland 4
France 4
Korea, Republic of 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Etomidate
Location Trials
Minnesota 3
California 2
Pennsylvania 2
Ohio 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Etomidate

Clinical Trial Phase

Clinical Trial Phase for Etomidate
Clinical Trial Phase Trials
Phase 4 38
Phase 3 3
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Etomidate
Clinical Trial Phase Trials
Completed 30
Recruiting 14
Unknown status 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Etomidate

Sponsor Name

Sponsor Name for Etomidate
Sponsor Trials
Tianjin Medical University General Hospital 3
The Cleveland Clinic 3
University Hospital Inselspital, Berne 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Etomidate
Sponsor Trials
Other 78
Industry 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
Express Scripts
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.